Ascendis Pharma A/S
ASND NASDAQHealthcare ★★★★★Latest Earnings FY2026 Q2 Above forecast↑
Date
Aug 13, 2026
ET
EPS Est.
1.71
EPS Actual
3.29
Revenue Est.
$376.8M
Revenue Actual
$387.5M
Next Earnings Report
Date
Nov 11, 2026 · Wed
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
1.24
Revenue Est.
$488.1M
Company Overview
Ascendis Pharma A/S (ticker ASND) is listed on NASDAQ with a market cap of about $15.73B. Its next earnings report (FY2026 Q3) is expected on Nov 11, 2026 (ET), Time TBD, with consensus EPS of 1.24. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 16, 2023 → FY2026 Q2
Feb 16, 2023Range: -3.96 ~ 3.29FY2026 Q2
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 13, 2026 | FY2026 Q2 | 1.71 | Above forecast↑3.29 | $376.8M | $387.5M |
| May 7, 2026 | -- | 0.19 | Above forecast↑0.32 | $308.9M | $284.9M |
| Feb 11, 2026 | -- | -0.06 | Below forecast↓-0.64 | $292.3M | $344.8M |
| Nov 12, 2025 | -- | -0.41 | Below forecast↓-1.17 | $302.6M | $250.2M |
| Aug 7, 2025 | -- | -1.42 | Above forecast↑-0.93 | $233.1M | $186.1M |
| May 1, 2025 | -- | -1.56 | -1.66 | $153.5M | $110.7M |
| Feb 12, 2025 | -- | -1.20 | Above forecast↑-0.68 | $125.4M | $180.1M |
| Nov 14, 2024 | -- | -1.83 | -1.81 | $74.1M | $63.4M |
| Sep 3, 2024 | -- | -1.54 | Below forecast↓-2.05 | $37.6M | $38.7M |
| May 2, 2024 | -- | -1.62 | Below forecast↓-2.48 | $92.4M | $103M |
| Feb 7, 2024 | -- | -2.19 | Above forecast↑-1.66 | $111.1M | $151.4M |
| Nov 7, 2023 | -- | -2.55 | Below forecast↓-3.08 | $55.3M | $50.7M |
| Sep 5, 2023 | -- | -2.68 | -2.35 | $43.5M | $55.4M |
| Apr 27, 2023 | -- | -2.93 | Above forecast↑-2.18 | $25.8M | $36.5M |
| Feb 16, 2023 | -- | -2.74 | Below forecast↓-3.96 | $22M | $24.7M |
Original Filings (SEC)
6-K2026-08-13 ↗
6-K2026-08-13 ↗
6-K2026-08-12 ↗
6-K2026-08-06 ↗
6-K2026-07-15 ↗
6-K2026-06-30 ↗
6-K2026-06-29 ↗
6-K2026-06-17 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
